Qiu S, Wang Q, Jiang H, Feng L
Diagn Pathol. 2024; 19(1):97.
PMID: 38992635
PMC: 11238443.
DOI: 10.1186/s13000-024-01523-z.
Sujatha T, Mullapudi Venkata S, Jayashankar E, Putcha U, Koturu S, Bhopal T
Cureus. 2022; 14(9):e29001.
PMID: 36249643
PMC: 9553749.
DOI: 10.7759/cureus.29001.
Angelico G, Santoro A, Inzani F, Straccia P, Spadola S, Arciuolo D
Diagnostics (Basel). 2021; 11(4).
PMID: 33923427
PMC: 8073999.
DOI: 10.3390/diagnostics11040713.
Major A, Dvorak V, Schwarzova J, Skrivanek A, Malik T, Pluta M
Arch Gynecol Obstet. 2020; 303(2):501-511.
PMID: 33219482
PMC: 7858556.
DOI: 10.1007/s00404-020-05816-8.
Zhang X, Shen D
Int J Clin Exp Pathol. 2020; 11(8):4109-4116.
PMID: 31949802
PMC: 6962782.
Progression of Precancerous Cervical Lesion Predicted by p16 Protein Immunohistochemistry in Rajavithi Hospital.
Charoonwatana T, Boonlikit S, Yanaranop M
Asian Pac J Cancer Prev. 2019; 20(6):1809-1815.
PMID: 31244304
PMC: 7021621.
DOI: 10.31557/APJCP.2019.20.6.1809.
Utility of P16/INK4a and Ki-67 in Preneoplasticand Neoplastic Lesions of Cervix.
Sangwaiya A, Gill M, Bairwa S, Chaudhry M, Sen R, Kataria S
Iran J Pathol. 2019; 13(3):308-316.
PMID: 30636953
PMC: 6322520.
Introduction of p16 as a surrogate biomarker for HPV in women with invasive cervical cancer in Sudan.
Sarwath H, Bansal D, Husain N, Mohamed M, Sultan A, Bedri S
Infect Agent Cancer. 2017; 12:50.
PMID: 29021820
PMC: 5622439.
DOI: 10.1186/s13027-017-0159-0.
Usefulness of p16 staining for managing histological high-grade squamous intraepithelial cervical lesions.
Miralpeix E, Genoves J, Sole-Sedeno J, Mancebo G, Lloveras B, Bellosillo B
Mod Pathol. 2016; 30(2):304-310.
PMID: 27739439
DOI: 10.1038/modpathol.2016.168.
[Modern biomarkers for precancerous lesions of the uterine cervix : Histological-cytological correlation and use].
Schmidt D
Pathologe. 2016; 37(6):534-541.
PMID: 27638536
DOI: 10.1007/s00292-016-0231-3.
TMEM45A, SERPINB5 and p16INK4A transcript levels are predictive for development of high-grade cervical lesions.
Manawapat-Klopfer A, Thomsen L, Martus P, Munk C, Russ R, Gmuender H
Am J Cancer Res. 2016; 6(7):1524-36.
PMID: 27508094
PMC: 4969401.
p16 staining has limited value in predicting the outcome of histological low-grade squamous intraepithelial lesions of the cervix.
Sagasta A, Castillo P, Saco A, Torne A, Esteve R, Marimon L
Mod Pathol. 2015; 29(1):51-9.
PMID: 26541274
DOI: 10.1038/modpathol.2015.126.
Expression of P16 in high-risk human papillomavirus related lesions of the uterine cervix in a government hospital, Malaysia.
Krishnappa P, Mohamad I, Lin Y, Barua A
Diagn Pathol. 2014; 9:202.
PMID: 25361681
PMC: 4228182.
DOI: 10.1186/s13000-014-0202-z.
Immunohistochemical Expression of Cell Proliferating Nuclear Antigen (PCNA) and p53 Protein in Cervical Cancer.
Madhumati G, Kavita S, Anju M, Uma S, Raj M
J Obstet Gynaecol India. 2013; 62(5):557-61.
PMID: 24082558
PMC: 3526699.
DOI: 10.1007/s13224-012-0180-6.
Cervical squamocolumnar junction-specific markers define distinct, clinically relevant subsets of low-grade squamous intraepithelial lesions.
Herfs M, Parra-Herran C, Howitt B, Laury A, Nucci M, Feldman S
Am J Surg Pathol. 2013; 37(9):1311-8.
PMID: 24076771
PMC: 3905241.
DOI: 10.1097/PAS.0b013e3182989ee2.
p16(INK4a) immunohistochemistry is a promising biomarker to predict the outcome of low grade cervical intraepithelial neoplasia: comparison study with HPV genotyping.
Nishio S, Fujii T, Nishio H, Kameyama K, Saito M, Iwata T
J Gynecol Oncol. 2013; 24(3):215-21.
PMID: 23875070
PMC: 3714458.
DOI: 10.3802/jgo.2013.24.3.215.
p16(INK4a) immunoprofiles of squamous lesions of the uterine cervix-implications for the reclassification of atypical immature squamous metaplasia.
Skapa P, Robova H, Rob L, Zamecnik J
Pathol Oncol Res. 2013; 19(4):707-14.
PMID: 23686439
DOI: 10.1007/s12253-013-9633-1.
Revised terminology for cervical histopathology and its implications for management of high-grade squamous intraepithelial lesions of the cervix.
Waxman A, Chelmow D, Darragh T, Lawson H, Moscicki A
Obstet Gynecol. 2012; 120(6):1465-71.
PMID: 23168774
PMC: 4054813.
DOI: 10.1097/aog.0b013e31827001d5.
Prevalence of human papilloma virus in cytological abnormalities: Association of risk factors and cytomorphological findings.
Izaaks C, Truter E, Khan S
Cytojournal. 2012; 9:19.
PMID: 22993533
PMC: 3440928.
DOI: 10.4103/1742-6413.100123.
Prediction of clinical outcome using p16INK4a immunocytochemical expression in low-grade squamous intraepithelial lesions and high-risk HPV-positive atypical squamous cells of undetermined significance in patients with and without colposcopic....
Lukic A, Sbenaglia G, Carico E, DI Properzio M, Giarnieri E, Frega A
Exp Ther Med. 2012; 2(5):853-858.
PMID: 22977588
PMC: 3440826.
DOI: 10.3892/etm.2011.316.